No Detail Found!

Roles of Il-36 in the Pathogenesis of Inflammatory Bowel Disease in a Sample of Iraqi Patients

Author(s)
ZAHRAA F. IBRAHEEM Department of Biology, College of education for pure science (Ibn- Al-Haytham)/ University of Baghdad, Iraq.
HANAN Y. MUHSIN Department of Biology, College of education for pure science (Ibn- Al-Haytham)/ University of Baghdad, Iraq.
Abstract
Background: IBD (Inflammatory bowel disease) is a chronic inflammatory condition that affects the intestines., in which cytokines are thought to have a role in the etiology and pathophysiology. IBD is divided into two types: Ulcerative Colitis (UC), and Crohn's Disease (CD). Aim of the study: The current study examined the level of, IL-36 in the blood of sixty IBD Iraqi patients (30 CD, 30 UC, and 30 HC). The concentrations were correlated with Age, age at onset, body mass index (BMI), cigarette-smoking status, disease duration, gender, symptoms, and extra-intestinal features. Result: The findings revealed that IL-36 level for UC & CD patients have been significantly higher than the healthy control). However, there was a significant difference in IL-36 levels between UC and CD patients p. When UC and CD patients were divided into subgroups based on certain features, it was discovered that IL-36 was significantly increased in CD patients with disease duration >10 year compared to UC patients). In addition, It was in BMI underweight, CD patients significantly increased compared, to UC patient. while in CD patient there was a significant difference between patients with BMI underweight compared to patients with BMI obese). In the case of, non-smoker patients there was a significant increase in CD patients compared to UC). Conclusion: the findings suggest that IL-36 has a role in the etiology & pathophysiology of IBD.
Publication Details
Page(s) 548-551
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Request the full text from PASTIC

Keywords
Body Mass Index, Disease Duration, Crohn's disease, Ulcerative colitis, Cd, UC, HC, IL-36, healthy control, cigarette-Smoking, and Inflammatory Bowel Disease., IBD
References
Abegunde A.T. .2016 .Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. , 22(27) : .
Ramos G.P.,Papadakis K.A. .2019 .Mechanisms of disease: inflammatory bowel diseases. in Mayo Clinic Proceedings, : .
Abdul-Hussein S.S. . .05N) in Iraqi patients with inflammatory bowel disease (ulcerative colitis and Crohn's disease). , 01 : 04.
.2021 .. , 22(1) : 1-10.
Witkowski M. .2018 .Recipe for IBD: can we use food to control inflammatory bowel disease? in Seminars in immunopathology. , : .
Mabardy A. .2017 .IBD: a growing and vulnerable cohort of hospitalized patients with Clostridium difficile infection. , 83(6) : .
Kuhnen A.J.S.C. .2019 .Genetic and environmental considerations for inflammatory bowel disease. , 99(6) : 1197-1207.
Zhang Y.-Y.J.W.j.o.g.W.,Li Y.-Y.J.W.j.o.g.W. .2014 .Inflammatory bowel disease: pathogenesis. , 20(1) : 91.
Fu S.-H. .2020 .Interplay between cytokine circuitry and transcriptional regulation shaping helper T cell pathogenicity and plasticity in inflammatory bowel disease. , 21(9) : 3379.
.2015 .. , 42(1) : 38-45.
Murrieta-Coxca J.M. .2019 .IL-36 cytokines: regulators of inflammatory responses and their emerging role in immunology of reproduction. , 20(7) : 1649.
Elias M. .2021 .IL-36 in chronic inflammation and fibrosis-bridging the gap?. , 131(2) : .
Motiam El,A. El .2021 .SUMOylation modulates the stability and function of PI3K-p110β. , 78(8) : 4053-4065.
Ngo V.L. .2021 .. IL‐36 cytokines and gut immunity, 163(2) : .
Gabay C.,J.E.J.J.o. C. . .Regulation and function of interleukin‐36 cytokines in homeostasis and pathological conditions. , : .
.2015 .. , 97(4) : 645-652.
Friedrich M. .2014 .IL-36γ Sustains a Proinflammatory Selfamplifying Loop with IL-17C in Anti-TNF-induced Psoriasiform Skin Lesions of Patients with Crohn's Disease. , 20(11) : 1891-1901.
Villumsen M. .2013 .. Risk of Inflammatory Bowel Disease following Bacille Calmette-Guérin and Smallpox Vaccination: A Populationbased Danish Case-Cohort Study, 19(8) : 1717-1724.
Fonseca-Camarillo G. .2018 .Differential expression of IL-36 family members and IL-38 by immune and nonimmune cells in patients with active inflammatory bowel disease. , : .
Neufert C.,M.F. Neurath R.J.E.O.o.B.T.,Atreya R.J.E.O.o.B.T. .2020 .Rationale for IL-36 receptor antibodies in ulcerative colitis. , 20(4) : 339-342.
Penha R. .2016 .IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose-dependently activated via IL36β and induces CD4+ lymphocyte proliferation. , 85 : 18-25.
Scheibe K. .2017 .IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo. , 66(5) : .
Ding L. .2018 .IL-36 cytokines in autoimmunity and inflammatory disease. , 9(2) : 2895.
Russell S. .2016 .IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation. , 9(5) : 1193-1204.
Medina-Contreras O. .2016 .Cutting edge: IL-36 receptor promotes resolution of intestinal damage. , 196(1) : 34-38.
Neurath M.F.J.C.,Reviews G.F. .2020 .-36 in chronic inflammation and cancer. , 55 : 70-79.
Sommerfeld S.D.,Interleukin- S.D. .2019 .-producing macrophages drive IL-17-mediated fibrosis. , 4(40) : eaax4783.
Mao R.,Rieder F.J.G. .2019 .Cooling down the hot potato: antiinterleukin 36 therapy prevents and treats experimental intestinal fibrosis. , 156(4) : 871-873.
0

Citations

0

Downloads

41

Views